Goldman Sachs
IBB icon

Goldman Sachs’s iShares Biotechnology ETF IBB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$314M Buy
2,482,142
+1,952,538
+369% +$247M 0.04% 362
2025
Q1
$67.7M Sell
529,604
-327,035
-38% -$41.8M 0.01% 885
2024
Q4
$113M Sell
856,639
-510,539
-37% -$67.5M 0.02% 622
2024
Q3
$199M Sell
1,367,178
-1,786,690
-57% -$260M 0.03% 447
2024
Q2
$433M Sell
3,153,868
-58,897
-2% -$8.08M 0.07% 228
2024
Q1
$441M Buy
3,212,765
+1,033,916
+47% +$142M 0.08% 220
2023
Q4
$296M Sell
2,178,849
-242,635
-10% -$33M 0.05% 311
2023
Q3
$296M Buy
2,421,484
+1,311,490
+118% +$160M 0.06% 253
2023
Q2
$141M Sell
1,109,994
-719,903
-39% -$91.4M 0.03% 495
2023
Q1
$236M Sell
1,829,897
-44,216
-2% -$5.71M 0.05% 313
2022
Q4
$246M Buy
1,874,113
+559,584
+43% +$73.5M 0.06% 302
2022
Q3
$154M Sell
1,314,529
-232,348
-15% -$27.2M 0.04% 440
2022
Q2
$182M Sell
1,546,877
-21,282
-1% -$2.5M 0.05% 382
2022
Q1
$204M Buy
1,568,159
+395,420
+34% +$51.5M 0.04% 376
2021
Q4
$179M Sell
1,172,739
-1,082,636
-48% -$165M 0.04% 427
2021
Q3
$365M Buy
2,255,375
+274,579
+14% +$44.4M 0.08% 205
2021
Q2
$324M Sell
1,980,796
-1,276,873
-39% -$209M 0.07% 221
2021
Q1
$490M Sell
3,257,669
-2,916,653
-47% -$439M 0.12% 130
2020
Q4
$935M Buy
6,174,322
+2,634,039
+74% +$399M 0.24% 48
2020
Q3
$479M Sell
3,540,283
-2,903,879
-45% -$393M 0.14% 106
2020
Q2
$881M Buy
6,444,162
+2,307,039
+56% +$315M 0.27% 49
2020
Q1
$446M Sell
4,137,123
-328,674
-7% -$35.4M 0.16% 100
2019
Q4
$538M Buy
4,465,797
+1,719,995
+63% +$207M 0.14% 119
2019
Q3
$273M Buy
2,745,802
+657,081
+31% +$65.4M 0.08% 243
2019
Q2
$228M Sell
2,088,721
-1,126,863
-35% -$123M 0.07% 297
2019
Q1
$360M Buy
3,215,584
+1,696,701
+112% +$190M 0.11% 154
2018
Q4
$146M Sell
1,518,883
-602,613
-28% -$58.1M 0.05% 406
2018
Q3
$259M Sell
2,121,496
-1,483,044
-41% -$181M 0.07% 284
2018
Q2
$396M Buy
3,604,540
+1,519,549
+73% +$167M 0.11% 157
2018
Q1
$223M Sell
2,084,991
-625,607
-23% -$66.8M 0.06% 347
2017
Q4
$289M Buy
2,710,598
+1,373,668
+103% +$147M 0.07% 269
2017
Q3
$446M Buy
1,336,930
+272,140
+26% +$90.8M 0.11% 139
2017
Q2
$330M Sell
1,064,790
-613,228
-37% -$190M 0.09% 185
2017
Q1
$492M Buy
1,678,018
+652,460
+64% +$191M 0.13% 107
2016
Q4
$272M Sell
1,025,558
-603,453
-37% -$160M 0.08% 212
2016
Q3
$472M Sell
1,629,011
-68,163
-4% -$19.7M 0.14% 87
2016
Q2
$437M Sell
1,697,174
-498,315
-23% -$128M 0.14% 93
2016
Q1
$573M Sell
2,195,489
-445,866
-17% -$116M 0.19% 73
2015
Q4
$894M Sell
2,641,355
-478,308
-15% -$162M 0.28% 33
2015
Q3
$946M Buy
3,119,663
+497,025
+19% +$151M 0.32% 23
2015
Q2
$968M Sell
2,622,638
-298,452
-10% -$110M 0.3% 31
2015
Q1
$1B Buy
2,921,090
+843,244
+41% +$290M 0.32% 29
2014
Q4
$630M Sell
2,077,846
-1,746,970
-46% -$530M 0.2% 63
2014
Q3
$1.05B Buy
3,824,816
+465,943
+14% +$127M 0.33% 24
2014
Q2
$863M Buy
3,358,873
+343,636
+11% +$88.3M 0.27% 39
2014
Q1
$713M Buy
3,015,237
+660,600
+28% +$156M 0.23% 48
2013
Q4
$535M Buy
2,354,637
+900,388
+62% +$204M 0.18% 83
2013
Q3
$305M Sell
1,454,249
-55,997
-4% -$11.7M 0.11% 135
2013
Q2
$263M Buy
+1,510,246
New +$263M 0.1% 153